BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27658663)

  • 1. Management of Duodenal Involvement During Retroperitoneal Lymph Node Dissection for Germ Cell Tumors.
    Jacob JM; Cary C; Jiang S; Foster RS; House MG
    Urology; 2017 Jan; 99():169-173. PubMed ID: 27658663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 3. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
    Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
    Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
    Djaladat H; Nichols C; Daneshmand S
    Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary trends in postchemotherapy retroperitoneal lymph node dissection: Additional procedures and perioperative complications.
    Cary C; Masterson TA; Bihrle R; Foster RS
    Urol Oncol; 2015 Sep; 33(9):389.e15-21. PubMed ID: 25573056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
    Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
    J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.
    Gerdtsson A; Håkansson U; Törnblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
    Eur Urol Oncol; 2020 Jun; 3(3):382-389. PubMed ID: 31506250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
    Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
    Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center Experience.
    Alanee SR; Carver BS; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
    Urology; 2016 Sep; 95():128-31. PubMed ID: 27235751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma.
    Sharma P; Sverrisson EF; Zargar-Shoshtari K; Fishman MN; Sexton WJ; Dickinson SI; Spiess PE; Poch MA; Gilbert SM; Pow-Sang JM
    Can J Urol; 2015 Aug; 22(4):7882-9. PubMed ID: 26267026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor.
    Luz MA; Kotb AF; Aldousari S; Brimo F; Tanguay S; Kassouf W; Aprikian AG
    World J Surg Oncol; 2010 Nov; 8():97. PubMed ID: 21062470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
    Considine S; Heaney R; Conroy R; Thornhill JA
    Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.
    Heidenreich A; Pfister D; Witthuhn R; Thüer D; Albers P
    Eur Urol; 2009 Jan; 55(1):217-24. PubMed ID: 18926622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
    Brown JA; Bihrle R; Foster RS
    Urology; 2008 May; 71(5):911-4. PubMed ID: 18342916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review.
    Notarfrancesco M; Fankhauser CD; Lorch A; Ardizzone D; Helnwein S; Hoch D; Hermanns T; Thalmann G; Beyer J
    Swiss Med Wkly; 2023 Apr; 153():40053. PubMed ID: 37080191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
    Beck SD; Foster RS; Bihrle R; Donohue JP; Einhorn LH
    Cancer; 2007 Sep; 110(6):1235-40. PubMed ID: 17665498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the Morbidity of Postchemotherapy Retroperitoneal Lymph Node Dissection for Testis Cancer in a National Cohort of Privately Insured Patients.
    Macleod LC; Rajanahally S; Nayak JG; Parent BA; Ramos JD; Schade GR; Holt SK; Dash A; Gore JL; Lin DW
    Urology; 2016 May; 91():70-6. PubMed ID: 26802801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.